“…We started from commercially available pyrazin-2-amine, from which the addition of N-bromosuccinimide afforded 5-bromopyrazin-2-amine in high yield. 22 Next, the 2,6dimethylphenyl substituent was introduced by Suzuki cross coupling, and the second bromination afforded the desired 3-bromo-5-(2,6-dimethylphenyl)pyrazin-2-amine. Next, it was transformed into the imidazole intermediate using a threesteps-in-one approach: 23 i.e., (i) treatment with triethyl orthoformate to afford an ethyl N-arylformimidate, 24 and (ii) direct condensation with 4-tert-butlyaniline in giving asymmetric N,N 0diarylformamidine, 25 (iii) followed by copper-catalyzed intramolecular C-N bond formation to yield the demanded 1-(4-(tbutyl)phenyl)-6-(2,6-dimethylphenyl)-1H-imidazo [4,5-b]pyrazine.…”